Sandbox vidit3
Drug | Clinical course | Stable |
---|---|---|
Physical examination | No evidence of heart failure | |
Functional class | I/II | |
6MWD | Greater than 400 m | |
Echocardiogram | RV size normal | |
Hemodynamics | RAP normal CI normal | |
BNP | Near normal or stable | |
Treatment | Oral therapy | |
Frequency of evaluation | Q 3 to Q 6 months | |
FC assessment | Every clinic visit | |
6MWT | Every clinic visit | |
Echocardiogram2 | Q 12 months/center dependent | |
BNP | center dependent | |
RHC | Clinical deterioration and center dependent |
Drug | Clinical course | Unstable |
---|---|---|
Physical examination | Signs of heart failure | |
Functional class | IV | |
6MWD | Less than 400 m | |
Echocardiogram | RV Enlargement | |
Hemodynamics | RAP high CI low | |
BNP | Elevated/Increasing | |
Treatment | Intravenous prostacyclin and/or combination treatment | |
Frequency of evaluation | Q 1 to Q 3 months | |
FC assessment | Every clinic visit | |
6MWT | Every clinic visit | |
Echocardiogram2 | Q 6 to Q 12 months/center dependent | |
BNP | center dependent | |
RHC | Q 6 to Q 12 months or clinical deterioration |